389 related articles for article (PubMed ID: 30791637)
21. Mechanisms of white matter damage in multiple sclerosis.
Lassmann H
Glia; 2014 Nov; 62(11):1816-30. PubMed ID: 24470325
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of axonal and neuronal damage in multiple sclerosis.
Dutta R; Trapp BD
Neurology; 2007 May; 68(22 Suppl 3):S22-31; discussion S43-54. PubMed ID: 17548565
[TBL] [Abstract][Full Text] [Related]
23. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
24. Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms.
Pukoli D; Vécsei L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628811
[TBL] [Abstract][Full Text] [Related]
25. Viral induced demyelination.
Stohlman SA; Hinton DR
Brain Pathol; 2001 Jan; 11(1):92-106. PubMed ID: 11145206
[TBL] [Abstract][Full Text] [Related]
26. Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.
Ziemssen T
J Neurol; 2005 Nov; 252 Suppl 5():v38-45. PubMed ID: 16254701
[TBL] [Abstract][Full Text] [Related]
27. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial Dysfunction and Multiple Sclerosis.
Barcelos IP; Troxell RM; Graves JS
Biology (Basel); 2019 May; 8(2):. PubMed ID: 31083577
[TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis: lessons from molecular neuropathology.
Lassmann H
Exp Neurol; 2014 Dec; 262 Pt A():2-7. PubMed ID: 24342027
[TBL] [Abstract][Full Text] [Related]
30. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
[TBL] [Abstract][Full Text] [Related]
31. [Neuronal injury in multiple sclerosis].
Correale J; Meli F; Ysrraelit C
Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
[TBL] [Abstract][Full Text] [Related]
32. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
33. [Immunity and neurodegeneration: new concepts in multiple sclerosis].
Lalive PH; Schluep M; Chofflon M; Du Pasquier R
Rev Med Suisse; 2006 May; 2(64):1166-8, 1170. PubMed ID: 16734188
[TBL] [Abstract][Full Text] [Related]
34. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
Fetisova E; Chernyak B; Korshunova G; Muntyan M; Skulachev V
Curr Med Chem; 2017; 24(19):2086-2114. PubMed ID: 28302008
[TBL] [Abstract][Full Text] [Related]
35. Grey matter pathology in multiple sclerosis.
Bö L; Geurts JJ; Mörk SJ; van der Valk P
Acta Neurol Scand Suppl; 2006; 183():48-50. PubMed ID: 16637929
[TBL] [Abstract][Full Text] [Related]
36. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
Gardner C; Magliozzi R; Durrenberger PF; Howell OW; Rundle J; Reynolds R
Brain; 2013 Dec; 136(Pt 12):3596-608. PubMed ID: 24176976
[TBL] [Abstract][Full Text] [Related]
37. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.
Owens T
Curr Opin Neurol; 2003 Jun; 16(3):259-65. PubMed ID: 12858060
[TBL] [Abstract][Full Text] [Related]
38. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Brück W
J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
[TBL] [Abstract][Full Text] [Related]
39. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
[TBL] [Abstract][Full Text] [Related]
40. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Faissner S; Plemel JR; Gold R; Yong VW
Nat Rev Drug Discov; 2019 Dec; 18(12):905-922. PubMed ID: 31399729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
